Tin tiếng Anh theo trình độ

World First: Scientists Use AI to Design a Universal Coronavirus Vaccine That Passes Human Trials

Scientists at the University of Cambridge and their spin-out company DIOSynVax have completed the first ever human clinical trial of a vaccine designed entirely by artificial intelligence. The trial enrolled 39 healthy volunteers and found that the AI-designed vaccine is safe and generates immune responses against multiple coronaviruses simultaneously, including SARS-CoV-2 and related bat viruses with pandemic potential. The vaccine was delivered using a needle-free micro fluid jet and represents a major step toward a universal coronavirus vaccine that could protect against future pandemic threats.